Between FDA and USDA greenlighting the sale of cultivated chicken in the US, the ground-breaking of a large-scale precision fermentation facilities and advances in molecular farming, 2023 has been a banner year for novel protein production. But the path forward for these technologies is far from clear with manufacturing backlogs and bottlenecks, additional regulatory hurdles and a tightening investment landscape.